MaxCyte, Inc.

The momentum for this stock is not very good. MaxCyte, Inc. is not a good value stock. MaxCyte, Inc. is not a good growth stock. MaxCyte, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in MaxCyte, Inc..

News

MaxCyte, Inc. (NASDAQ:MXCT) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Ticker Report Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of MaxCyte, Inc. (NASDAQ:MXCT - Free Report) by 22.1% in the second quarter, Holdings Channel reports. The institutional investor...\n more…

MaxCyte management to meet with Stephens

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

MaxCyte Director Executes Options, Sells Shares

TipRanks Financial Blog MaxCyte (MXCT) has released an update. MaxCyte Inc.'s Non-Executive Director, Stanley Erck, has exercised options and sold shares, representing a significant transa...\n more…

MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference

Globe Newswire ROCKVILLE, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...\n more…

MaxCyte management to meet with Stephens

John Joseph Johnston Sells 3,000 Shares of MaxCyte, Inc. (NASDAQ:MXCT) Stock

Zolmax MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) Director John Joseph Johnston sold 3,000 shares of the business's stock in a transaction on Monday, August 26th. The stock was sold at an average price...\n more…